KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Common Equity (2016 - 2025)

Historic Common Equity for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to -$565.0 million.

  • Bausch Health Companies' Common Equity fell 13347.11% to -$565.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$565.0 million, marking a year-over-year decrease of 13347.11%. This contributed to the annual value of -$1.3 billion for FY2024, which is 2514.68% down from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Common Equity is -$565.0 million, which was down 13347.11% from -$764.0 million recorded in Q2 2025.
  • Over the past 5 years, Bausch Health Companies' Common Equity peaked at $433.0 million during Q3 2022, and registered a low of -$1.3 billion during Q4 2024.
  • Over the past 5 years, Bausch Health Companies' median Common Equity value was -$174.0 million (recorded in 2024), while the average stood at -$282.8 million.
  • Per our database at Business Quant, Bausch Health Companies' Common Equity surged by 86470.59% in 2022 and then tumbled by 57988.51% in 2025.
  • Quarter analysis of 5 years shows Bausch Health Companies' Common Equity stood at -$34.0 million in 2021, then soared by 864.71% to $260.0 million in 2022, then plummeted by 493.08% to -$1.0 billion in 2023, then dropped by 25.15% to -$1.3 billion in 2024, then surged by 55.82% to -$565.0 million in 2025.
  • Its last three reported values are -$565.0 million in Q3 2025, -$764.0 million for Q2 2025, and -$1.2 billion during Q1 2025.